The impact of concurrent bacterial lung infection on immunotherapy in patients with non-small cell lung cancer: a retrospective cohort study

OBJECTIVE: To find out how bacterial lung infections (BLI) affect the effectiveness of therapy and the rate of pneumonia caused by pneumonia related to checkpoint inhibitors (CIP) in patients with non-small cell lung cancer (NSCLC) who are getting immunotherapy with checkpoint inhibitors (ICIs). PAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Qiang, Wu, Xinyan, Chen, Yuquan, Wei, Qi, You, Yanwei, Qiang, Yi, Cao, Guangzhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497767/
https://www.ncbi.nlm.nih.gov/pubmed/37712056
http://dx.doi.org/10.3389/fcimb.2023.1257638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497767/
https://www.ncbi.nlm.nih.gov/pubmed/37712056
http://dx.doi.org/10.3389/fcimb.2023.1257638

Ejemplares similares